Cell Cryopreservation Market
Size is projected to achieve a value of USD 14.11 Billion in 2023, with a
linear behavior in the market growth it is forecasted to achieve a value of USD
61.75 Billion by 2033 with a CAGR of 18.75% during the forecast period 2024-2033.
We Market Research
cryopreservation is a technique that allows for the preservation of cells at
extremely low temperatures by stopping their biological activity and metabolic
processes. Typically, this is done in liquid nitrogen. By carefully controlling
the freezing process, cells are maintained in a state of suspended animation
that maintains their viability over time. This technique prevents cellular
degeneration and allows for long-term storage, which is essential in many
fields like as biotechnology, research, and medicine. It facilitates the
preservation of different cell types, including tissues and stem cells, making
them more suitable for use in future medical procedures, organ transplants, and
market for cell cryopreservation is propelled by multiple causes, including the
progress made in regenerative medicine, the increasing need for biobanking, and
the growing range of applications for stem cell research. Market growth is
driven by expanding applications in personalized medicine, drug discovery, and
the creation of cell-based therapeutics. Furthermore, a rise in chronic
illnesses and higher investments in healthcare infrastructure enhance the
demand for cell preservation technology. Additionally, the growing
biotechnology industry and the increasing emphasis on maintaining uncommon cell
types—like immune cells for immunotherapy—contribute substantially to the
market's growth trajectory by encouraging the development and use of novel cell
Market Size in 2023
Market Forecast in 2033
CAGR % 2024-2033
Consumption, company share, company heatmap, company production capacity,
growth factors and more
By Type, By Application, By End User and
Europe, APAC, South America and Middle East and Africa
U.S.; Canada; U.K.; Germany; France; Italy;
Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea;
Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE;
Egypt; South Africa; Nigeria
Cell Cryopreservation Industry: Dynamics & Restrains
Advancements in Biomedical Research - The
market for cell cryopreservation is driven by developments in biomedical
research, which increases consumer demand for long-term cell storage. Preserved
cells are necessary for advancements in stem cell therapy, regenerative
medicine, and customized care. As a result of this need, more effective
cryopreservation methods are being developed, guaranteeing cell viability and
functionality after thawing. Furthermore, the market for cryopreservation
technologies that meet particular needs for cell preservation is being driven
by the need to retain a variety of cell types, which is becoming more and more
necessary as research reveals new therapeutic applications and discoveries.
These developments are in line with innovations in biomedicine, creating a mutually
beneficial relationship that propels the expansion of the cell cryopreservation
Rising Awareness and Acceptance of Cell
Cryopreservation - The
market for cell cryopreservation is growing mostly due to increased
acceptability and understanding of the practice. Growing public, scientific,
and healthcare professional awareness of the advantages of long-term cell
preservation encourages increased use of the technique in biobanking, research,
and therapeutic applications. Acceptance rises as educational programs
emphasize how it enables cutting-edge therapies and guarantees a steady supply
of viable cells. This increased knowledge increases the market for cell
cryopreservation solutions suited to different requirements and applications by
expanding the pool of prospective users and stimulating investment in infrastructure,
technology, and research.
Technical Challenges and Limitations - The
market for cell cryopreservation is severely constrained by technical issues
and constraints. Even with advances, some cell types are still susceptible to
freezing and thawing, which can result in reduced viability or usefulness after
preservation. The dependability and broad use of cryopreservation procedures
are hampered by the possibility of cell injury, the creation of ice crystals,
and inconsistent preservation protocols. In order to overcome these
technological obstacles, ongoing innovation is needed to improve cell survival
rates, establish more robust cryopreservation techniques, and refine methods.
This will ensure broader application across a variety of cell types and
increase market confidence in the product's efficacy.
Cell Cryopreservation Segmentation
Market- By Type Analysis
By Type, the Cell Cryopreservation Market is Categories into Consumables, Equipment, Cell Freezing Media, Others. The Consumables segment accounts for the largest share of around 42% in 2022.
This is mostly because end users are using
cryovials, cryotubes, and other consumables more frequently because of their
advantages, which include reduced contamination. The market will expand as a
result of other factors such as the increasing incidence of chronic illnesses,
the expanding need for biologics, and the growing desire among end users for
following segments are part of an in-depth analysis of the Cell
Pharmaceutical and Biotechnology Company
Cell Cryopreservation Industry: Regional Analysis
North America Market Forecast
North America dominate the Cell Cryopreservation Market with the highest revenue generating market with share of more than 46%. Cell cryopreservation methods are in high demand due to a high frequency of chronic diseases, an advanced healthcare infrastructure, and major R&D investments. Growth is also being driven by the presence of significant market participants and encouraging government initiatives for cell-based therapeutics and regenerative medicine.
Europe Market Statistics
is the second-largest market for Cell Cryopreservation. Europe is fortunate to
have a strong healthcare system and significant research funding. The need for
cell cryopreservation methods is further fueled by the region's aging
population and rising knowledge of personalized medicine.
APAC Market Forecasts
Pacific is expected to be the fastest-growing market for Cell Cryopreservation
during the forecast period. The region's main drivers include a growing
population, rapid economic development, and rising healthcare costs. The market
for cell cryopreservation is expanding as a result of improvements in
healthcare infrastructure and an increase in the incidence of chronic diseases.
Positive government initiatives and an increasing emphasis on biotechnology and
life sciences also have a major role.
Cell Cryopreservation Market is dominated by a few large companies, such as
Lonza Group Ltd.
Cardinal Health, Inc.
BioLife Solutions, Inc.
Organ Recovery Systems
Thermo Fisher Scientific
Custom Biogenic Systems
Takara Bio Inc.
Chart Industries, Inc.
are some of the key trends that are shaping the competitive landscape of the Cell
2022, AMSBIO has
introduced 'STEM-CELLBANKER EX,' a state-of-the-art cryopreservation solution
designed to accelerate the development of cell therapy products. This
chemically defined cryopreservation medium solution offers a superior method
for maintaining stem cells and advances the study and development of cell
therapy. It contains inert components that are approved for intravenous
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Cell Cryopreservation Market was valued at USD 13.10 Billion in 2022.
Cell Cryopreservation Market size will increase at approximate CAGR of 18.75% during the forecasted period.
Major companies operating within the Cell Cryopreservation Market are GE Healthcare, Helmer Scientific, Lonza Group Ltd., Cardinal Health, Inc., Merck KGaA, STEMCELL Technologies Inc., BioLife Solutions, Inc., Cryolife, Inc., Organ Recovery Systems Inc., Thermo Fisher Scientific Inc., Custom Biogenic Systems, Sartorius AG, Takara Bio Inc., Chart Industries, Inc., Biocision, LLC and Other.
North America dominates the market with an active share of 46%.
Only Three Thousand Nine Hundred Fifty US dollar
Only Four Thousand Nine Hundred Fifty US dollar
Only Five Thousand Nine Hundred Fifty US dollar